YOLFTbeta
00

PKU HealthCare Corp Ltd

000788 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

5.38CNY-0.12 (-2.18%)

Price History

Full chart

Market Stats

Previous Close5.50
Open5.48
Day Range5.36 – 5.54
52-Week Range4.66 – 7.85
Volume13.82M
Market Cap3.25B
P/E (TTM)91.00
Forward P/E65.36
EPS0.06
Dividend Yield4.18%
Beta0.16
50-Day Avg5.48
200-Day Avg5.85

About

PKU HealthCare Corp.,Ltd. engages in the research, development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers anti-infectives, analgesics, psychotropic drugs, digestive system drugs, and cardiovascular drugs; procurement and pharmacy outsourcing; and cancer screening, health management, and treatment services related to healthcare management and care delivery, as well as involved in distribution, retail, and hospital sales of pharmaceuticals, medical devices, and consumables. It also provides ceftriaxone sodium, meropenem, and cefminox sodium for injection; moxifloxacin hydrochloride injection; clindamycin palmitate hydrochloride granules; naphazoline capsules; celecoxib capsules; dextroketoneprofen tablets and capsules; buspirone hydrochloride tablets; and olanzapine tablets. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. PKU HealthCare Corp.,Ltd. was founded in 1993 and is headquartered in Chongqing, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Xiren Xu
  • Employees789
  • HeadquartersPalm Springs International Center, Chongqing, China, 401121, China
  • Websitehttps://www.pku-hc.com

Leadership

  • Mr. Xiren XuNon-Independent Chairman & President · b. 1979
  • Mr. Quan Bo ZhaoVP & CFO · b. 1972
  • Mr. Yu Fei YuanSecretary of the Board · b. 1972
  • Mr. Qing Kai HeVice President · b. 1971
  • Mr. Mengchuan YuVice President · b. 1964
  • Liao CuiAccounting Supervisor

Financials

Income Statement

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue318.63M313.31M318.27M373.31M284.40M229.57M280.84M271.27M264.53M325.71M428.26M472.03M500.27M547.56M552.52M879.45M1.30B1.96B1.95B2.32B2.27B2.01B2.07B2.15B2.32B2.51B1.98B2.24B2.08B2.19B2.06B1.48B
Growth (%)--1.67%+1.58%+17.29%-23.82%-19.28%+22.33%-3.41%-2.48%+23.13%+31.49%+10.22%+5.98%+9.45%+0.91%+59.17%+47.72%+50.54%-0.40%+18.92%-2.19%-11.26%+2.96%+3.65%+7.92%+8.35%-21.19%+13.12%-7.13%+5.61%-6.10%-28.04%
Cost of Revenue241.20M234.48M232.02M273.13M228.86M192.57M253.53M212.24M245.26M277.15M345.84M380.32M417.85M455.88M448.39M636.17M985.00M1.55B1.60B1.90B1.87B1.76B1.67B1.58B1.51B1.56B1.09B1.33B1.31B1.48B1.51B1.07B
Gross Profit77.43M78.83M86.25M100.19M55.55M37.00M27.31M59.03M19.28M48.56M82.41M91.71M82.42M91.68M104.13M243.28M314.10M402.05M351.67M413.47M390.89M249.69M399.85M565.97M807.24M953.19M884.44M908.96M772.12M711.92M548.39M415.56M
Gross Margin24.30%25.16%27.10%26.84%19.53%16.12%9.73%21.76%7.29%14.91%19.24%19.43%16.47%16.74%18.85%27.66%24.18%20.56%18.05%17.85%17.25%12.42%19.31%26.37%34.86%37.99%44.73%40.64%37.17%32.45%26.62%28.03%
Operating Expense24.99M30.04M34.07M34.48M46.34M100.92M124.19M71.55M139.30M98.12M70.45M79.04M69.28M84.05M95.20M171.82M219.15M276.44M249.72M324.85M423.38M294.38M371.06M525.98M742.67M879.80M828.92M847.05M700.64M633.48M376.39M257.29M
Operating Income52.44M48.79M52.18M65.70M9.21M-63.92M-96.88M-12.52M-120.02M-49.56M11.96M12.68M13.13M7.63M8.93M71.45M94.95M125.62M101.95M88.62M-32.49M-44.68M28.79M39.98M64.57M73.39M55.52M61.91M71.48M78.44M172.00M158.27M
Operating Margin16.46%15.57%16.39%17.60%3.24%-27.84%-34.50%-4.62%-45.37%-15.22%2.79%2.69%2.62%1.39%1.62%8.12%7.31%6.42%5.23%3.83%-1.43%-2.22%1.39%1.86%2.79%2.92%2.81%2.77%3.44%3.58%8.35%10.68%
EBITDA55.64M56.30M62.70M70.75M14.11M-24.54M-41.74M44.14M-103.15M56.46M51.94M50.09M51.10M26.18M92.41M160.15M369.25M207.86M165.90M184.97M170.08M229.43M77.00M64.03M92.77M96.07M87.97M105.84M115.04M110.39M206.49M159.49M
EBITDA Margin17.46%17.97%19.70%18.95%4.96%-10.69%-14.86%16.27%-38.99%17.34%12.13%10.61%10.21%4.78%16.72%18.21%28.42%10.63%8.52%7.99%7.51%11.41%3.72%2.98%4.01%3.83%4.45%4.73%5.54%5.03%10.02%10.76%
Net Income54.93M53.10M51.79M56.14M21.75M-49.76M-92.36M4.73M-152.67M5.05M12.11M13.01M13.27M14.09M14.39M65.33M270.04M115.20M76.17M78.02M-27.10M25.03M12.56M34.26M45.18M50.19M39.18M43.14M55.61M44.36M137.99M82.88M
Net Income Margin17.24%16.95%16.27%15.04%7.65%-21.67%-32.89%1.75%-57.71%1.55%2.83%2.76%2.65%2.57%2.60%7.43%20.79%5.89%3.91%3.37%-1.20%1.24%0.61%1.60%1.95%2.00%1.98%1.93%2.68%2.02%6.70%5.59%
R&D----------------10.28M11.98M32.75M33.28M62.69M11.87M5.17M7.59M5.99M16.08M8.71M19.31M14.74M27.80M27.04M26.86M
R&D as % of Total Revenue----------------0.79%0.61%1.68%1.44%2.77%0.59%0.25%0.35%0.26%0.64%0.44%0.86%0.71%1.27%1.31%1.81%
Interest Expense4.59M8.33M11.18M6.00M16.02M13.79M18.87M22.79M23.21M17.91M10.58M14.23M14.30M15.55M15.42M27.69M29.14M23.86M22.08M27.27M79.42M76.31M29.29M8.21M11.73M13.48M16.76M22.95M18.64M7.16M4.37M2.38M
Interest Expense % of Total Revenue1.44%2.66%3.51%1.61%5.63%6.01%6.72%8.40%8.77%5.50%2.47%3.01%2.86%2.84%2.79%3.15%2.24%1.22%1.13%1.18%3.51%3.80%1.41%0.38%0.51%0.54%0.85%1.03%0.90%0.33%0.21%0.16%

Balance Sheet

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets428.95M563.37M628.98M922.71M1.03B971.37M956.09M901.53M785.67M650.41M771.34M714.21M737.94M760.69M801.36M1.32B1.98B2.75B3.64B4.23B4.61B3.12B2.04B2.08B2.14B2.46B2.31B2.54B2.64B2.44B2.29B1.99B
Total Liabilities254.82M362.13M375.96M364.13M449.59M511.69M588.77M613.32M661.06M479.25M564.04M493.88M469.58M456.68M485.12M738.30M1.13B1.71B2.54B3.05B3.48B1.99B903.46M904.70M933.89M1.21B1.01B1.21B1.26B1.02B776.42M431.58M
Total Equity174.14M201.24M253.02M558.57M580.32M459.68M367.32M288.21M124.61M171.16M207.30M220.32M268.36M285.17M298.30M538.15M811.04M1.00B1.06B1.14B1.11B1.13B1.14B1.18B1.21B1.25B1.30B1.34B1.38B1.42B1.51B1.56B
Cash14.70M30.56M24.80M101.88M32.11M21.81M11.97M59.08M16.74M33.79M98.77M62.08M52.52M71.41M98.00M203.02M638.18M414.47M592.42M718.75M632.28M1.34B491.20M419.99M520.55M668.91M476.96M446.26M633.52M457.25M617.33M909.30M
Total Debt161.24M242.92M256.02M197.64M219.27M246.20M293.93M345.25M330.83M132.70M186.33M237.17M239.10M210.00M182.00M395.25M626.89M798.10M1.35B1.64B1.57B1.17B166.88M154.80M129.90M313.44M341.52M354.20M169.75M82.14M40.80M-
Net Debt146.54M212.36M231.22M95.77M187.16M224.39M281.96M286.17M314.09M98.91M87.56M175.10M186.59M138.59M84.00M192.22M-11.29M383.63M758.10M922.67M940.87M-170.04M-324.32M-265.19M-390.65M-355.48M-221.68M-92.06M-442.31M-375.12M-576.53M-

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-13.97M-78.06M-35.03M34.51M-41.59M129.33M34.72M1.05M24.75M57.86M-135.55M110.61M79.11M96.19M89.07M165.99M408.67M-116.94M-26.34M204.37M-5.78M-68.14M59.14M278.90M121.84M347.75M387.29M
Investing Cash Flow-57.94M-24.07M-3.66M13.33M-4.12M-21.99M-66.50M-41.32M-30.61M-2.27M-79.73M-47.72M104.98M-467.29M-377.02M-175.07M-255.37M210.52M319.17M-10.79M-36.92M-40.77M-58.09M-45.40M-35.33M-81.79M-39.18M-
Financing Cash Flow2.14M91.83M28.86M-2.58M3.37M-87.57M42.28M36.62M-13.89M-25.77M-43.42M-14.01M210.45M41.45M463.68M195.40M-185.32M159.42M-904.83M-19.83M-43.41M158.65M-74.76M-31.10M-92.45M-207.64M-68.07M-
Capital Expenditure57.67M24.83M3.82M5.34M4.28M22.06M67.37M42.17M31.36M5.79M81.30M46.91M308.75M477.03M383.67M278.91M217.12M150.89M22.56M11.06M37.08M41.41M58.09M45.40M35.32M63.20M39.37M48.77M
Free Cash Flow-71.64M-102.89M-38.86M29.17M-45.87M107.27M-32.65M-41.11M-6.61M52.07M-81.30M88.64M-198.14M-397.92M-287.48M-189.84M-51.13M257.78M-139.49M-37.40M167.29M-47.19M-126.23M13.74M243.57M58.65M308.38M338.53M
Dividends Paid19.96M20.40M18.87M22.79M13.68M3.66M11.34M14.23M15.84M15.55M15.42M27.69M30.35M95.11M91.33M91.65M101.45M72.12M27.85M8.25M18.51M11.92M13.52M19.31M27.57M3.87M46.45M36.57M
FCF to OCF512.93%131.82%110.91%84.54%110.28%82.94%-94.04%-3903.72%-26.70%89.99%-65.39%-179.14%-502.97%-298.87%-213.12%-30.80%63.08%119.29%141.99%81.86%816.19%185.25%23.24%87.33%48.13%88.68%87.41%
Dividend Paid to FCF-27.87%-19.82%-48.57%78.13%-29.82%3.42%-34.74%-34.60%-239.69%29.87%-18.96%31.24%-15.32%-23.90%-31.77%-48.28%-198.43%27.98%-19.96%-22.07%11.06%-25.26%-10.71%140.51%11.32%6.60%15.06%10.80%

Earnings

Report DateJun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 15, 2016Oct 26, 2016Dec 31, 2016Apr 28, 2017Aug 29, 2017Oct 25, 2017Dec 31, 2017Apr 20, 2018Aug 24, 2018Oct 19, 2018Dec 31, 2018Apr 15, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 29, 2020Aug 28, 2020Oct 29, 2020Dec 31, 2020Apr 21, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------
EPS Actual0.030.03-0.14-0.14-0.06-0.110.350.010.010.01-0.000.010.020.010.010.020.020.020.010.030.020.020.010.020.020.030.000.040.020.04-0.020.020.030.030.020.030.030.02-0.000.070.070.070.010.080.090.06-0.090.050.05
Surprise-------------------------------------------------
Timing--------After-hoursPre-market-After-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursPre-market-Pre-market-----------------------------

Key Statistics & Ratios

Market Cap3.25B
Enterprise Value2.28B
Trailing P/E91.00
Forward P/E65.36
PEG Ratio0.00
Price / Sales3.35
Price / Book2.12
EPS0.06
Book Value2.55
Revenue (TTM)972.17M
Gross Profit (TTM)318.97M
EBITDA136.95M
Profit Margin3.94%
Operating Margin15.60%
Return on Equity2.46%
Return on Assets3.16%
Shares Outstanding595.99M
Shares Float408.44M
Beta0.16
Dividend Yield4.18%
Dividend Rate0.23
Payout Ratio3.08%

Dividends

20262×
0.02Nov 3, 20260.17Mar 10, 2026
20252×
0.03Oct 13, 20250.03Jun 17, 2025
20242×
0.05Nov 27, 20240.03Jul 16, 2024
20221×
0.02Jun 17, 2022
20191×
0.02May 29, 2019
20181×
0.01Jun 20, 2018
20141×
0.01May 23, 2014
20131×
0.01May 24, 2013
20121×
0.03May 17, 2012
20111×
0.07Mar 18, 2011

Stock Splits

  • Mar 18, 201114:10
  • Apr 13, 201016:10
  • Apr 20, 200615.01:10
  • Jul 3, 19981.1:1